was conducted to examine the efficacy of fenfluramine on GTCS reduction in various types of Developmental and Epileptic Encephalopathies or rare epilepsy conditions. Data from 13 studies , 4.
21 scientific presentations, including 7 late breakers, showcase the breadth of UCB s portfolio, reinforcing commitment to improving the lives of people living.
Miku Joins Forces with Boston Children s Hospital in Research Study to Develop Seizure Detection Solution streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Eisai Inc. announced today that new data on its antiepileptic drug FYCOMPA® (perampanel) CIII will be presented at the 75th American Epilepsy.